5-43039551-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001014279.3(ANXA2R):āc.496C>Gā(p.Leu166Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001014279.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANXA2R | NM_001014279.3 | c.496C>G | p.Leu166Val | missense_variant | 1/1 | ENST00000616064.2 | NP_001014301.1 | |
ANXA2R-OT1 | NR_104651.1 | n.214-24401C>G | intron_variant, non_coding_transcript_variant | |||||
ANXA2R | NM_001382352.1 | c.496C>G | p.Leu166Val | missense_variant | 2/2 | NP_001369281.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANXA2R | ENST00000616064.2 | c.496C>G | p.Leu166Val | missense_variant | 1/1 | NM_001014279.3 | ENSP00000479862 | P1 | ||
ANXA2R-OT1 | ENST00000503152.2 | n.227-24401C>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461432Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 726990
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2023 | The c.496C>G (p.L166V) alteration is located in exon 1 (coding exon 1) of the ANXA2R gene. This alteration results from a C to G substitution at nucleotide position 496, causing the leucine (L) at amino acid position 166 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.